SHIM
WST icon

Stone House Investment Management’s West Pharmaceutical WST Stock Holding History

Stone House Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.62K Buy
24
+13
+118% +$3.97K ﹤0.01% 461
2026
Q1 		$2.76K Buy
11
+8
+267% +$1.99K ﹤0.01% 545
2025
Q4 		$825 Hold
3
– – ﹤0.01% 660
2025
Q3 		$787 Buy
+3
New +$729 ﹤0.01% 587

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Stone House Investment Management's WST Position: Q2 2026 in Review

Stone House Investment Management increased its West Pharmaceutical (WST) stake by 118% in Q2 2026, buying an estimated $3.97K and bringing the position to 24 shares worth $8.62K. The position accounts for ﹤0.01% of the portfolio, ranked #461.

Stone House Investment Management first reported a position in WST in Q3 2025 and has held it in 4 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Stone House Investment Management held 24 shares of West Pharmaceutical worth $8.62K as of Q2 2026.
  • Stone House Investment Management bought 13 West Pharmaceutical shares in Q2 2026, an estimated $3.97K.
  • West Pharmaceutical made up ﹤0.01% of Stone House Investment Management's portfolio in Q2 2026, its #461 holding.
  • Stone House Investment Management first reported a position in West Pharmaceutical in Q3 2025 and has held it in 4 quarters since.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Stone House Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.